T-type Ca2+ channel enhancer SAK3 administration improves the BPSD-like behaviors in AppNL−G-F/NL−G-F knock-in mice

Publication date: Available online 26 February 2021Source: Journal of Pharmacological SciencesAuthor(s): Tomohide Degawa, Ichiro Kawahata, Hisanao Izumi, Yasuharu Shinoda, Kohji Fukunaga

Source: Journal of Pharmacological Sciences - March 5, 2021 Category: Drugs & Pharmacology Source Type: research